Defect alert

Phebra has initiated a product defect alert for bottles of Ospolot (sulthiame) 200mg tablets Phebra Pty Ltd, in conjunction with the TGA, made the announcement on Thursday after it was identified that the child-resistant caps may not function correctly. “If this occurs, a child may be able to open a bottle and access the medicine,